GLUCOSE METABOLISM DISORDERS
Clinical trials for GLUCOSE METABOLISM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new GLUCOSE METABOLISM DISORDERS trials appear
Sign up with your email to follow new studies for GLUCOSE METABOLISM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
NMN supplement shows promise for prediabetes in early human test
Disease control CompletedThis study tested whether a supplement called nicotinamide mononucleotide (NMN) can improve how the body handles sugar in people with prediabetes. Researchers gave NMN to 56 adults with higher-than-normal blood sugar and measured changes in insulin sensitivity and glucose toleran…
Matched conditions: GLUCOSE METABOLISM DISORDERS
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Money stress and diabetes: new study tests a Two-Pronged solution
Disease control CompletedThis pilot study tested whether combining financial navigation (help with costs) and peer support (connecting with others) can help adults with diabetes better manage their condition. 61 participants were randomly assigned to receive either financial navigation alone or financial…
Matched conditions: GLUCOSE METABOLISM DISORDERS
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Electric pulses to the gut: a new hope for diabetes?
Disease control CompletedThis early study tested a device that uses mild electric pulses to regenerate the lining of the upper small intestine in 20 adults with type 2 diabetes. The goal was to see if the procedure is safe and could help lower blood sugar. Participants were on 2-3 diabetes pills and had …
Matched conditions: GLUCOSE METABOLISM DISORDERS
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New diabetes drug shows promise for teens in landmark trial
Disease control CompletedThis study tested a medication called tirzepatide in children and teenagers aged 10 to 17 with type 2 diabetes. Participants were already taking metformin or insulin but still had high blood sugar. The goal was to see if tirzepatide could safely lower blood sugar levels better th…
Matched conditions: GLUCOSE METABOLISM DISORDERS
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC